In this acute intervention study, we investigated the potential benefit of ketone supplementation in humans by studying cardiac phosphocreatine to adenosine-triphosphate ratios (PCr/ATP) and... Show moreIn this acute intervention study, we investigated the potential benefit of ketone supplementation in humans by studying cardiac phosphocreatine to adenosine-triphosphate ratios (PCr/ATP) and skeletal muscle PCr recovery using phosphorus magnetic resonance spectroscopy (P-31-MRS) before and after ingestion of a ketone ester drink. We recruited 28 healthy individuals: 12 aged 23-70 years for cardiac P-31-MRS, and 16 aged 60-75 years for skeletal muscle P-31-MRS. Baseline and post-intervention resting cardiac and dynamic skeletal muscle P-31-MRS scans were performed in one visit, where 25 g of the ketone monoester, deltaG(R), was administered after the baseline scan. Administration was timed so that post-intervention P-31-MRS would take place 30 min after deltaG(R) ingestion. The deltaG(R) ketone drink was well-tolerated by all participants. In participants who provided blood samples, post-intervention blood glucose, lactate and non-esterified fatty acid concentrations decreased significantly (-28.8%, p MUCH LESS-THAN 0.001; -28.2%, p = 0.02; and -49.1%, p MUCH LESS-THAN 0.001, respectively), while levels of the ketone body D-beta-hydroxybutyrate significantly increased from mean (standard deviation) 0.7 (0.3) to 4.0 (1.1) mmol/L after 30 min (p MUCH LESS-THAN 0.001). There were no significant changes in cardiac PCr/ATP or skeletal muscle metabolic parameters between baseline and post-intervention. Acute ketone supplementation caused mild ketosis in blood, with drops in glucose, lactate, and free fatty acids; however, such changes were not associated with changes in P-31-MRS measures in the heart or in skeletal muscle. Future work may focus on the effect of longer-term ketone supplementation on tissue energetics in groups with compromised mitochondrial function. Show less
